(Q35151493)

6 August 2017

title

Long-term administration of desferrioxamine in thalassaemia major (English)

1 reference

6 August 2017

1 reference

Seshadri R

1

1 reference

6 August 2017

Colebatch JH

series ordinal

2

1 reference

6 August 2017

Gordon P

series ordinal

3

1 reference

6 August 2017

Ekert H

series ordinal

4

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 August 1974

1 reference

Archives of Disease in Childhood

6 August 2017

published in

1 reference

6 August 2017

volume

49

1 reference

6 August 2017

issue

8

1 reference

6 August 2017

page(s)

621-626

1 reference

Generalized siderosis with fibrosis of liver and pancreas in Cooley's (Mediterranean) anemia; with observations on the pathogenesis of the siderosis and fibrosis.

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1648977

Desferrioxamine in thalassaemia

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1648977

Storage iron and desferrioxamine.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1648977

EXcretion and distribution of iron during chronic deferoxamine therapy

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1648977

Clinical usefulness of iron chelating agents

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1648977

Urinary iron excretion in thalassaemia after desferrioxamine administration

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1648977

Proceedings: 5-year controlled trial of chelating agents in treatment of thalassaemia major

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1648977

Clinical experience with intensive transfusion therapy in Cooley's anemia.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1648977

Some clinical features of Cooley's anemia patients as related to transfusion schedules

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1648977

Serum-immunoglobulin levels in thalassaemia and the effects of splenectomy

27 September 2018

1 reference

12 December 2020

Iron excretion in thalassemia after the administration of chelating agents

1 reference

12 December 2020

Deferoxamine and diethylenetriaminepentaacetic acid (DTPA) in thalassemia

1 reference

12 December 2020

EVALUATION OF DEFEROXAMINE IN IRON OVERLOAD

1 reference

12 December 2020

Diagnosis of iron storage disease with desferrioxamine (Desferal test)

1 reference

12 December 2020

Application of Atomic Absorption Spectrophotometry in the Determination of Iron in Urine

1 reference

12 December 2020

LATE CARDIAC COMPLICATIONS OF CHRONIC, SEVERE, REFRACTORY ANEMIA WITH HEMOCHROMATOSIS

1 reference

12 December 2020

TRANSFUSION HEMOCHROMATOSIS IN COOLEY'S ANEMIA

1 reference

12 December 2020

Identifiers

DOI

10.1136/ADC.49.8.621

1 reference

6 August 2017

1 reference

6 August 2017

1 reference